Teva Launches Generic Version of Axiron in United States
Filed with ASX · · 1 page · English
In the deck
Story so far
Earlier from Acrux
- Axiron Net Sales Quarter to 30 June 2017
- Axiron Generic Launched In The United States
- Institution of IPR Proceeding Against Key Jublia Patent
- Axiron Net Sales Quarter to 31 March 2017
- Appendix 4D and Half Year Report to 31 December 2016
Later from Acrux
- Appendix 4E and 2017 Financial Report
- Axiron License Agreement Terminated
- Axiron Net Sales Quarter to September 2017
- Axiron Patents Appeal Decision
- Axiron Net Sales Quarter to December 2017
Follow Acrux into a list and get an email when it puts out news.
Follow Acrux